Description

+ Include: 12 videos + 1 pdf, size: 3.74 GB

+ Target Audience: Cardiologists, Endocrinologists, Internists, General Practitioners

+ Sample video: contact me for sample video

+ Topics:

brochure_lipids21_compressed.pdf

Cardiometabolic Disease and Novel Therapies SGLT2 Inhibitors and GLP1 Agonists.mp4

Cardiovascular Prevention in Women.mp4

Evaluation of Subclinical Coronary Atherosclerosis, Coronary CTA and Coronary Calcium Score.mp4

Exercise and Cardiovascular Risk.mp4

Influence of Elevated Triglycerides on Atherosclerosis and Non-Statin Therapies-Review of Data Omega 3, Bempedoic Acid, Niacin, Ezetimibe, PCSK9 Inhibitors.mp4

New Concepts in Dyslipidemia Dispelling 10 Common Health “Truths” About Lipids and Risk Assessment.mp4

Optimizing Dietary Pattern in Patients with Cardiovascular Disease.mp4

Panel Discussion Q&A 1.mp4

Panel Discussion Q&A 2.mp4

Panel Discussion Q&A 3.mp4

The Utility of Polygenic Risk Scores in Primary Prevention of Atherosclerotic Cardiovascular Disease.mp4

Update on Inflammation and Novel Biomarkers for Atherosclerosis.mp4